Galenika - the only bigger privatization in regional pharmaceutical sector

Source: seebiz.eu Sunday, 07.02.2010. 16:45
Comments
Podeli

The sale of Serbian pharmaceutical company Galenika is the only big announced privatization in that field in the region of Southeast Europe.

The deadline for submission of pre-qualification bids is February 19, 2010, and bidders are required to have minimum five years of experience in pharmaceutical industry and the income from sales of pharmaceutical products in 2008 of over 100m EUR. The financial investors who had over 250m EUR to manage in 2008 are also allowed to submit bids.

- According to previous information, none of the companies with the headquarters in Southeast Europe is among the interested companies - said the analysts from Erste Group. According to their estimate, the fact that the region of Southeast Europe is keeping up with the other regions, in conjunction with demographic factors such as aging population, growing awareness of health care and constant progress in launching innovative drugs, should drive the pharmaceutics markets in the years to come.

Erste Group's analysts are of the opinion that the best pharmaceutical companies in the region are ready to achieve solid business results, although, due to restrictive measures for the prices of drugs that will be refunded, the tempo might be a bit slower than before the crisis.


- Also, the stocks of regional pharmaceutical companies, which represent a sanctuary in the time of turbulence and uncertainty, will keep affecting the investors' changing mood in 2010. With the current values, which are much below earlier maximum, the stocks of the best pharmaceutical companies in Southeast Europe are maintaining their long-term attractiveness - it is estimated in the analysis.

Comments
Your comment
Full information is available only to commercial users-subscribers and it is necessary to log in.

Forgot your password? Click here HERE

For free test use, click HERE

Follow the news, tenders, grants, legal regulations and reports on our portal.
Registracija na eKapiji vam omogućava pristup potpunim informacijama i dnevnom biltenu
Naš dnevni ekonomski bilten će stizati na vašu mejl adresu krajem svakog radnog dana. Bilteni su personalizovani prema interesovanjima svakog korisnika zasebno, uz konsultacije sa našim ekspertima.